• Gavi's partnership model

in page functions
  • Two key factors set the Vaccine Alliance apart from other actors in the field of international health aid:

    • The partnership model: as a public-private partnership, Gavi capitalises on the sum of its partners’ comparative advantages;
    • The business model: by funding the delivery of new vaccines, Gavi shapes the vaccine market.

    In this section, we explain Gavi’s partnership model and profile the role of each of the Vaccine Alliance’s members.

    WHO Olivier Asselin SLE09 0225 GAVI 0255
  • The World Health Organization


    As a co-founder of Gavi and the UN's specialist agency on global health issues, WHO is a key implementing partner.



    As the world's biggest buyer and supplier of vaccines for developing countries, UNICEF has a pivotal role in the Vaccine Alliance.

  • The World Bank

    World Bank

    The World Bank brings the expertise of the world's biggest source of development assistance to the Vaccine Alliance.

  • Developing country governments

    GAVI/2011/Riccardo Gangale

    Developing countries are the most important part of the Vaccine Alliance. They apply for support, manage grants and finance immunisation programmes.

  • Civil society

    CSO Partnership Model

    CSOs help deliver vaccines to remote communities, implement vaccine programmes and advocate for immunisation.

  • Research and technical health institutes

    John Hopkins Hospital

    Partnership with the research community allows Gavi to tap in the latest information and thinking from the scientific, medical and product delivery communities.

close icon

modal window here